SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Johnson Pharmacare Ltd

BSE: 532154 NSE: ISIN: INE560F01022
  |   Sector:  Miscellaneous   |   Industry:  Trading

Snapshot

Q.1 Which industry/sub-sector does Johnson Pharmacare Ltd belong to?
Johnson Pharmacare Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.2 Is Johnson Pharmacare Ltd a good quality company?
Johnson Pharmacare Ltd is a quality company, based on a 4-year financial track record.
Q.3 Is Johnson Pharmacare Ltd undervalued or overvalued?
Johnson Pharmacare Ltd appears Somewhat overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Johnson Pharmacare Ltd a good buy now?
Johnson Pharmacare Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd revenue growth is 0% for FY-2025, which is above its 3-year CAGR of -100%, indicating faster growth.
Q.2 Return on capital employed (ROCE) of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd Return on capital employed is -1.01% for FY-2025, which is in line with its 3-year historical median of -1.01%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.
Q.3 Return on Asset of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd Return on Asset is -0.99%, which is in line with its 3-year historical median of -0.99%, indicating stable asset utilization efficiency.
Q.4 Return on Equity (ROE) of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd Return on equity is -1.03% for FY-2025, which is in line with its 3-year historical median of -1.03%, indicating the business is making similar use of its shareholders capital.
Q.5 Gross Profit margin of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd Gross profit margin which is the profit after deduction of direct costs, is -52.6% for FY-2025, which is below its 3-year median of 0.2%, indicating decreasing margins.
Q.6 Operating Profit Margin of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 0% for FY-2025, which is below its 3-year median of 4.13% indicating decreasing margins.
Q.7 Net Profit Margin of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd Net Profit Margin is -% for FY-2025, is below with its 3-year median of 0.15%, indicating decreasing margins.
Current Level 3-year
Historic Median
Gross Profit Margin -52.6 0.2
Operating Profit Margin - 4.13
Net Profit Margin - 0.15
Q.8 Debt to Equity ratio of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd Debt-to-Equity ratio is 0.01, which is lower with the industry average of 0.19, indicating lower debt levels in the industry.
Q.9 Debt to cash flow from operations of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd Debt to cash flow from operations is -0.32, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Johnson Pharmacare Ltd?
Promoters hold 0.00% of the Johnson Pharmacare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Johnson Pharmacare Ltd vs industry peers?
Johnson Pharmacare Ltd revenue CAGR is -100.00%, compared to the industry median CAGR of 13.25%, indicating slower growth and losing its market share.
Profit Metrics
Current Level 3-year
Industry Median
Revenue Growth - 13.3
Gross Profit Growth 0 NAN
Operating Profit Growth 0 16.4
Net Profit Growth 0 NAN
Operating Efficiency
Current Level 3-year
Industry Median
Asset Turnover - 0.97
ROE -1.03 3.61
ROCE -1.01 4.53
Cash Conversion Cycle (days) - 66

Valuation & price assessment

Q.1 Stock return of Johnson Pharmacare Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 2.8% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price
CAGR		 2.8% 19.3% 1.2% -36.3%
Q.3 Valuation ratios of Johnson Pharmacare Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios compare with 3-year historical median and industry numbers?
Valuation Ratios Current 3-year
Historic Median		 3-year
Industry Median
Price to Earnings - -637.75 35.02
Price to Book 0.57 0.81 1.68
Price to Sales - 11.10 2.16
EV to EBITDA -78.14 -117.58 15.53

Check more companies

1. Aditya Infotech
2. Aegis Logistics
3. Redington
4. RRP Semiconductor
5. Honasa Consumer
6. Lloyds Enterprises
7. MMTC
8. Cello World
9. Jeena Sikho Life
10. SG Mart

Check trending companies

1. Jindal Saw Ltd.
2. Union Bank Of India
3. Lloyds Metals & Energy Ltd.
4. Astral Ltd.
5. Max Healthcare Institute Ltd.
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×